Downloads: 1
| # | nr | Sample.ID | Patient.ID | Dataset | Treatment | Treatment_status | Chemo_status | Endo_status | Response_type | Response | Response_coded | Timepoint | Timepoint_coded | Platform | Platform_comp | scmod1 | pam50 | ClaudinLow | Mammaprint_risk | Mammaprint_score | rorS_risk | rorS_score | IC10 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 37 | NEO48_T1 | C1.48 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumB | Others | 1 | -0.093446088794926 | Intermediate | 42.2141407491511 | iC8 |
| 2 | 43 | NEO19_T1 | C1.19 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.150528541226216 | High | 70.8868448895502 | iC8 |
| 3 | 34 | NEO46_T1 | C1.46 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- High Prolif | LumB | Others | 1 | 0.0522903453136011 | High | 70.4382337364229 | iC7 |
| 4 | 7 | NEO3_T1 | C1.3 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.500070472163495 | High | 64.221183672051 | iC10 |
| 5 | 24 | NEO14_T1 | C1.14 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Her2 | Others | 1 | -0.0658210007047216 | High | 98.8091765126301 | iC4 |
| 6 | 27 | NEO34_T1 | C1.34 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumA | Others | 0 | -0.338830162085976 | Low | 14.0798192004774 | iC1 |
| 7 | 12 | NEO22_T1 | C1.22 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.320225510923185 | High | 79.5143908743625 | iC10 |
| 8 | 8 | NEO17_T1 | C1.17 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumB | Others | 1 | 0.168710359408034 | High | 64.6001470505453 | iC4 |
| 9 | 44 | NEO24_T1 | C1.24 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | Her2 | Others | 1 | 0.334319943622269 | High | 100.0 | iC5 |
| 10 | 14 | NEO26_T1 | C1.26 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | Her2 | Others | 1 | -0.0807610993657505 | High | 90.0573237692095 | iC4 |
| 11 | 21 | NEO18_T1 | C1.18 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.264834390415786 | High | 100.0 | iC10 |
| 12 | 42 | NEO12_T1 | C1.12 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | Her2 | Others | 1 | -0.0126849894291755 | Intermediate | 38.1959867528771 | iC5 |
| 13 | 38 | NEO36_T1 | C1.36 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | Her2 | Others | 1 | 0.0964059196617336 | High | 91.727476759361 | iC5 |
| 14 | 45 | NEO39_T1 | C1.39 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.256941508104299 | Low | 23.4040392328419 | iC3 |
| 15 | 28 | NEO20_T1 | C1.20 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumB | Others | 1 | 0.0945736434108527 | High | 82.457303135808 | iC9 |
| 16 | 29 | NEO20_T2 | C1.20 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER+/HER2- High Prolif | LumB | Others | 1 | -0.212544045102185 | Intermediate | 47.8530338171237 | iC7 |
| 17 | 16 | NEO23_T2 | C1.23 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.221987315010571 | High | 60.9410806582251 | iC5 |
| 18 | 4 | NEO15_T2 | C1.15 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.112755461592671 | Intermediate | 38.6481506459179 | iC4 |
| 19 | 25 | NEO14_T2 | C1.14 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Normal | Others | 0 | -0.433967582804792 | Intermediate | 30.662468446638 | iC4 |
| 20 | 22 | NEO18_T2 | C1.18 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.121353065539112 | High | 99.4535021363968 | iC10 |
| 21 | 20 | NEO5_T2 | C1.5 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.411557434813249 | Low | 4.20517701579802 | iC3 |
| 22 | 10 | NEO21_T1 | C1.21 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.185341789992953 | Intermediate | 50.205490193119 | iC4 |
| 23 | 32 | NEO29_T1 | C1.29 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.386469344608879 | High | 72.3117455361466 | iC4 |
| 24 | 17 | NEO8_T1 | C1.8 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.459901338971106 | High | 68.9501392369943 | iC9 |
| 25 | 36 | NEO47_T1 | C1.47 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Normal | Others | 0 | -0.312755461592671 | Low | 0.0 | iC4 |
| 26 | 35 | NEO30_T1 | C1.30 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.507681465821001 | Low | 1.79544463733132 | iC4 |
| 27 | 5 | NEO16_T1 | C1.16 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- High Prolif | LumB | Others | 1 | -0.285835095137421 | High | 65.3908297397626 | iC1 |
| 28 | 26 | NEO33_T1 | C1.33 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- High Prolif | LumA | Others | 1 | -0.28231148696265 | Low | 23.8178735815116 | iC6 |
| 29 | 23 | NEO27_T1 | C1.27 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.400563777307963 | Intermediate | 32.0407552737033 | iC8 |
| 30 | 18 | NEO8_T2 | C1.8 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.102184637068358 | High | 60.8960310823949 | iC4 |
| 31 | 6 | NEO16_T2 | C1.16 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | 2 weeks | T2 | GPL17303 | Ampliseq | ER+/HER2- High Prolif | LumB | Others | 0 | -0.334601832276251 | High | 59.8848783391753 | iC1 |
| 32 | 46 | NEO42_T1 | C1.42 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.263002114164905 | Low | 13.0614301602051 | iC8 |
| 33 | 15 | NEO23_T1 | C1.23 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.477660324171952 | High | 75.7534936854924 | iC10 |
| 34 | 41 | NEO50_T1 | C1.50 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | LumA | Others | 1 | -0.233121916842847 | Intermediate | 37.5022033905893 | iC3 |
| 35 | 3 | NEO15_T1 | C1.15 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.51430584918957 | High | 55.3774144391629 | iC9 |
| 36 | 19 | NEO5_T1 | C1.5 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumB | Others | 1 | 0.295560253699789 | High | 95.4803340763772 | iC1 |
| 37 | 2 | NEO11_T2 | C1.11 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.483439041578576 | Intermediate | 52.2594715427177 | iC10 |
| 38 | 9 | NEO17_T2 | C1.17 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Her2 | Others | 1 | 0.14122621564482 | High | 81.2639139828492 | iC4 |
| 39 | 39 | NEO49_T1 | C1.49 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.318675123326286 | High | 75.4566746190501 | iC3 |
| 40 | 33 | NEO45_T1 | C1.45 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.160394644115574 | Intermediate | 34.6596433623736 | iC3 |
| 41 | 40 | NEO51_T1 | C1.51 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.384073291050035 | Low | 0.0 | iC7 |
| 42 | 11 | NEO21_T2 | C1.21 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Normal | Others | 1 | -0.108668076109937 | Low | 27.0603681175431 | iC4 |
| 43 | 1 | NEO11_T1 | C1.11 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER-/HER2- | Basal | Others | 1 | 0.600281888653982 | High | 67.0390927943672 | iC10 |
| 44 | 13 | NEO22_T2 | C1.22 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | 2 weeks | T2 | GPL17303 | Ampliseq | ER-/HER2- | Normal | Others | 1 | -0.264552501761804 | High | 56.6048823910082 | iC4 |
| 45 | 30 | NEO43_T1 | C1.43 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Non_responder | 0 | Pre-treatment | T1 | GPL17303 | Ampliseq | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.150528541226216 | Low | 0.0 | iC3 |
| 46 | 31 | NEO13_T1 | C1.13 | C1 | Chemotherapy | 1 | 1 | 0 | pCR | Responder | 1 | Pre-treatment | T1 | GPL17303 | Ampliseq | HER2+ | LumB | Others | 1 | -0.108245243128964 | High | 100.0 | iC5 |
| 47 | 126 | GSM808189 | C2.1155 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.495137420718816 | High | 85.5485134626944 | iC3 |
| 48 | 79 | GSM808141 | C2.1038 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.125017618040874 | High | 72.6113857755951 | iC4 |
| 49 | 128 | GSM808191 | C2.1161 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | 0.271317829457364 | High | 84.0690026840895 | iC5 |
| 50 | 145 | GSM808209 | C2.1192 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | -0.0374911909795631 | Low | 13.5798031784418 | iC1 |
| 51 | 76 | GSM808138 | C2.1051 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- Low Prolif | LumA | Others | 1 | -0.195771670190275 | Low | 0.0 | iC3 |
| 52 | 122 | GSM808184 | C2.1162 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | 0.320507399577167 | Intermediate | 52.541785946158 | iC5 |
| 53 | 75 | GSM808137 | C2.1085 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumB | Others | 1 | 0.111064129668781 | Intermediate | 52.7700933499285 | iC1 |
| 54 | 171 | GSM808239 | C2.1228 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | 0.294009866102889 | High | 66.7859352132321 | iC5 |
| 55 | 107 | GSM808169 | C2.1121 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.315715292459478 | High | 94.4433086230152 | iC10 |
| 56 | 94 | GSM808156 | C2.1078 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | -0.126145172656801 | Low | 27.5479259487234 | iC3 |
| 57 | 102 | GSM808164 | C2.1126 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.0455250176180409 | High | 56.4269519188548 | iC3 |
| 58 | 87 | GSM808149 | C2.1129 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | 0.322198731501057 | High | 94.208215476659 | iC5 |
| 59 | 148 | GSM808212 | C2.1208 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.169556025369979 | High | 100.0 | iC4 |
| 60 | 112 | GSM808174 | C2.1113 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | 0.0173361522198732 | Intermediate | 43.9759898537826 | iC1 |
| 61 | 89 | GSM808151 | C2.1058 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.412403100775194 | High | 97.9791183000095 | iC10 |
| 62 | 97 | GSM808159 | C2.1099 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.505285412262156 | High | 76.9481319726241 | iC4 |
| 63 | 86 | GSM808148 | C2.1128 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | -0.0245243128964059 | High | 73.7312521971578 | iC1 |
| 64 | 92 | GSM808154 | C2.1075 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Normal | Others | 1 | 0.0553911205073996 | Intermediate | 36.0743209551173 | iC4 |
| 65 | 137 | GSM808201 | C2.1176 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | -0.0863988724453841 | High | 70.5603403553365 | iC5 |
| 66 | 147 | GSM808211 | C2.1215 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | 0.220436927413672 | High | 73.0281617073103 | iC5 |
| 67 | 118 | GSM808180 | C2.1148 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Her2 | Others | 1 | 0.116420014094433 | High | 81.5862964774116 | iC4 |
| 68 | 124 | GSM808186 | C2.1163 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.261169837914024 | High | 85.8551852485836 | iC6 |
| 69 | 132 | GSM808196 | C2.1145 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.0469344608879493 | High | 68.4968179245171 | iC3 |
| 70 | 119 | GSM808181 | C2.1144 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.356871035940803 | High | 100.0 | iC4 |
| 71 | 72 | GSM808134 | C2.1045 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.272868217054264 | High | 94.1462682136992 | iC10 |
| 72 | 56 | GSM808113 | C2.1011 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.481747709654686 | High | 87.0078859084643 | iC10 |
| 73 | 67 | GSM808129 | C2.1077 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | HER2+ | LumB | Others | 1 | 0.263706835799859 | High | 73.6193968919548 | iC5 |
| 74 | 158 | GSM808225 | C2.1239 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.455813953488372 | Low | 0.0 | iC3 |
| 75 | 162 | GSM808229 | C2.1220 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Her2 | Others | 1 | 0.14630021141649 | High | 93.5591920325751 | iC3 |
| 76 | 152 | GSM808219 | C2.1227 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.180972515856237 | High | 79.9163471165629 | iC3 |
| 77 | 198 | GSM808269 | C2.1051 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.539816772374912 | Low | 0.0 | iC3 |
| 78 | 190 | GSM808261 | C2.1038 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.149682875264271 | High | 80.9626648442935 | iC4 |
| 79 | 191 | GSM808262 | C2.1039 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | HER2+ | Her2 | Others | 1 | -0.117265680056378 | High | 64.1313964926904 | iC7 |
| 80 | 206 | GSM808277 | C2.1078 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER+/HER2- High Prolif | Normal | Others | 1 | 0.0298801973220578 | Intermediate | 39.1916035410194 | iC3 |
| 81 | 203 | GSM808274 | C2.1063 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER+/HER2- Low Prolif | Basal | Others | 1 | 0.00648343904157858 | High | 60.9891598856668 | iC4 |
| 82 | 201 | GSM808272 | C2.1058 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.433262861169838 | High | 99.7171439816374 | iC10 |
| 83 | 196 | GSM808267 | C2.1045 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.378435517970402 | High | 86.778265135161 | iC10 |
| 84 | 215 | GSM808286 | C2.1125 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Responder | 1 | 24-96 hours | T2 | GPL14668 | Agilent | ER+/HER2- Low Prolif | LumA | Others | 0 | -0.357434813248767 | Low | 4.35797900447464 | iC8 |
| 85 | 96 | GSM808158 | C2.1100 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumB | Others | 1 | 0.0121212121212121 | Intermediate | 52.253939123571 | iC3 |
| 86 | 77 | GSM808139 | C2.1054 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.291331923890063 | High | 92.2874125350615 | iC5 |
| 87 | 93 | GSM808155 | C2.1069 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | -0.134178999295278 | Low | 25.1952433257844 | iC3 |
| 88 | 50 | GSM808107 | C2.1022 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 0 | -0.368992248062015 | Intermediate | 46.3726703560676 | iC8 |
| 89 | 129 | GSM808193 | C2.1152 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | -0.0818886539816772 | Intermediate | 33.12690082878 | iC2 |
| 90 | 84 | GSM808146 | C2.1055 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | 0.133192389006343 | Low | 11.8560056667518 | iC3 |
| 91 | 134 | GSM808198 | C2.1173 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.537279774489077 | High | 91.4472938239673 | iC9 |
| 92 | 161 | GSM808228 | C2.1218 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.384355179704017 | High | 97.6621584527807 | iC3 |
| 93 | 131 | GSM808195 | C2.1142 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.574489076814658 | High | 67.6834043939215 | iC9 |
| 94 | 123 | GSM808185 | C2.1165 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Normal | Others | 1 | 0.181254404510218 | Intermediate | 34.4868949799076 | iC4 |
| 95 | 121 | GSM808183 | C2.1151 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | 0.08907681465821 | Intermediate | 46.8356331163501 | iC4 |
| 96 | 117 | GSM808179 | C2.1147 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.481747709654686 | High | 72.0472935612934 | iC3 |
| 97 | 49 | GSM808105 | C2.1002 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumB | Others | 1 | -0.0452431289640592 | High | 53.4462597643552 | iC6 |
| 98 | 91 | GSM808153 | C2.1062 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER-/HER2- | Basal | Others | 1 | 0.42861169837914 | High | 93.289513488524 | iC10 |
| 99 | 173 | GSM808241 | C2.1081 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumB | Others | 1 | -0.052431289640592 | High | 97.7834262396348 | iC3 |
| 100 | 149 | GSM808213 | C2.1206 | C2 | Chemotherapy | 1 | 1 | 0 | RCB, cutoff: >1 | Non_responder | 0 | Pre-treatment | T1 | GPL14668 | Agilent | ER+/HER2- High Prolif | LumA | Others | 1 | -0.120507399577167 | Intermediate | 37.4478865914164 | iC2 |